Primary Pulmonary Hypertension

Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
Wen-Hui Wu, Sébastien Bonnet, Tsukasa Shimauchi, Victoria Toro, Yann Grobs, Charlotte Romanet, Alice Bourgeois, Geraldine Vitry, Junichi Omura, Eve Tremblay, Valerie Nadeau, Mark Orcholski, Sandra Breuils-Bonnet, Sandra Martineau, Pasquale Ferraro, Francois Potus, Roxane Paulin, Steeve Provencher, Olivier Boucherat

Thorax Jul 2021, thoraxjnl-2021-217377; DOI: 10.1136/thoraxjnl-2021-217377
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
Peter Heukels, Odilia B J Corneth, Denise van Uden, Jennifer A C van Hulst, Leon M van den Toorn, Annemien E van den Bosch, Marlies S Wijsenbeek, Karin A Boomars, Mirjam Kool, Rudi W Hendriks

Thorax May 2021, thoraxjnl-2020-215460; DOI: 10.1136/thoraxjnl-2020-215460
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study
Andrew J Swift, Frederick Wilson, Marcella Cogliano, Lindsay Kendall, Faisal Alandejani, Samer Alabed, Paul Hughes, Yousef Shahin, Laura Saunders, Charlotte Oram, David Capener, Alex Rothman, Pankaj Garg, Christopher Johns, Matthew Austin, Alistair Macdonald, Jo Pickworth, Peter Hickey, Robin Condliffe, Anthony Cahn, Allan Lawrie, Jim M Wild, David G Kiely

Thorax Feb 2021, thoraxjnl-2020-216078; DOI: 10.1136/thoraxjnl-2020-216078
Review of the British Thoracic Society Winter Meeting 2018, 5–7 December 2018, London, UK
Amanda T Goodwin, Aran Singanayagam, Gisli Jenkins

Thorax Dec 2019, 74 (12) 1168-1173; DOI: 10.1136/thoraxjnl-2019-213680
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
Lars Harbaum, Pavandeep Ghataorhe, John Wharton, Beatriz Jiménez, Luke S G Howard, J Simon R Gibbs, Jeremy K Nicholson, Christopher J Rhodes, Martin R Wilkins

Thorax Apr 2019, 74 (4) 380-389; DOI: 10.1136/thoraxjnl-2018-212144
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
Jurjan Aman, G. Kees Hovingh

Thorax Apr 2019, 74 (4) 317-318; DOI: 10.1136/thoraxjnl-2018-212840
TAKling GDF-15 and skeletal muscle atrophy in pulmonary hypertension: are we there yet?
Yen-Chun Lai, Steeve Provencher, Elena A Goncharova

Thorax Feb 2019, 74 (2) 103-105; DOI: 10.1136/thoraxjnl-2018-212680
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension
Benjamin E Garfield, Alexi Crosby, Dongmin Shao, Peiran Yang, Cai Read, Steven Sawiak, Stephen Moore, Lisa Parfitt, Carl Harries, Martin Rice, Richard Paul, Mark L Ormiston, Nicholas W Morrell, Michael I Polkey, Stephen John Wort, Paul R Kemp

Thorax Feb 2019, 74 (2) 164-176; DOI: 10.1136/thoraxjnl-2017-211440
Pulmonary hypertension with warm hands
Liza Botros, Jurjan Aman, Harm Jan Bogaard, Anton Vonk Noordegraaf

Thorax Dec 2017, 72 (12) 1164-1166; DOI: 10.1136/thoraxjnl-2017-209982
Pulmonary endarterectomy for calcified amorphous tumour-related pulmonary hypertension
Peter I Bonta, Harm J Bogaard, Inge van den Berk, Hans W M Niessen, Allard van der Wal, Petr Symersky

Thorax Jun 2017, 72 (6) 584-585; DOI: 10.1136/thoraxjnl-2016-208939

Main menu

Primary Pulmonary Hypertension

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Primary Pulmonary Hypertension

Pages